| Cerebri Biofeedback Feasibility Trial (NCT05454319) | Nordic Brain Tech AS | 2022-06-01 |
| The Effects of Vitamin D Plus Omega-3 Polyunsaturated Fatty Acids in Patients With Episodic Migraine (NCT05449145) | Kuang Tien General Hospital | 2022-05-01 |
| Sphenopalatine Ganglion Blockade in Migraine (NCT05210192) | Afyonkarahisar Health Sciences University | 2022-04-01 |
| i-NEED: NEw migrainE Drugs Database (NCT07103694) | IRCCS San Raffaele Roma | 2022-03-24 |
| Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention (NCT05207865) | Pfizer | 2022-03-15 |
| Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine (NCT05264129) | AbbVie | 2022-03-07 |
| Effectiveness of Multimodal Physical Therapy in Migraine (NCT05226559) | Neuromed IRCCS | 2022-02-24 |
| A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine (NCT05127486) | Eli Lilly and Company | 2021-12-06 |
| Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine (NCT05028569) | AbbVie | 2021-11-05 |
| Transnasal Cooling for Migraine (NCT04936061) | CoolTech LLC | 2021-10-14 |
| My Healthy Diary - An Electronic Diary for Remote Migraine Monitoring (NCT04828941) | Unidade Local de Saúde de Matosinhos, EPE | 2021-03-28 |
| Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments. (NCT04740827) | Allergan | 2021-03-05 |
| A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine (NCT04686136) | AbbVie | 2021-02-19 |
| CGRP Inhibition, Autonomic Function, and Migraine (NCT04628429) | Medical University of Vienna | 2020-10-01 |
| A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine (NCT04437433) | AbbVie | 2020-06-18 |
| Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain (NCT04166045) | Theranova, L.L.C. | 2020-06-12 |
| HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs (NCT06155123) | IRCCS National Neurological Institute "C. Mondino" Foundation | 2020-01-14 |
| A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine (NCT03963232) | Eli Lilly and Company | 2019-07-30 |
| Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients (NCT03927144) | Amgen | 2019-05-15 |
| Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine (NCT03939312) | Allergan | 2019-05-06 |
| Occipital Blocks for Acute Migraine (NCT03526874) | Children's Hospital of Philadelphia | 2019-04-03 |
| 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine (NCT03777059) | Allergan | 2018-12-14 |
| Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine (NCT03700320) | Allergan | 2018-10-08 |
| A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (NCT03432286) | Eli Lilly and Company | 2018-03-14 |
| Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients (NCT03333109) | Novartis Pharmaceuticals | 2018-02-08 |
| Energy for the Brain (NCT03132233) | University Hospital, Basel, Switzerland | 2017-05-08 |
| A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies (NCT03096834) | Novartis Pharmaceuticals | 2017-03-20 |
| DFN-11 Injection in Episodic Migraine With or Without Aura (NCT02569853) | Dr. Reddy's Laboratories Limited | 2015-09-21 |
| Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine (NCT02176018) | Cady, Roger, M.D. | 2014-08-01 |
| The Role of Left Prefrontal Transcranial Magnetic Stimulation in Episodic Migraine Prophylaxis (NCT04031781) | Ain Shams University | 2013-05-01 |
| Pilot Study to Collect and Evaluate Data on the Use of IV* Ibuprofen in the Treatment of an Acute Migraine Attack (NCT01230411) | Thomas Jefferson University | 2011-06-01 |
| Aspirin Resistance in Women With Migraine (NCT01257893) | Swedish Medical Center | 2010-11-01 |
| fMRI of the Brainstem in Migraine Sufferers and Controls. Does Iron Deposition Correlate With Progression of Disease? (NCT00868556) | The Cleveland Clinic | 2009-01-01 |
| The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache (NCT00719134) | Beth Israel Deaconess Medical Center | 2008-09-01 |